Current and future prospects of nitro-compounds as drugs for trypanosomiasis and leishmaniasis

S Patterson, AH Fairlamb - Current Medicinal Chemistry, 2019 - ingentaconnect.com
Interest in nitroheterocyclic drugs for the treatment of infectious diseases has undergone a
resurgence in recent years. Here we review the current status of monocyclic and bicyclic …

Discovery of novel drugs for Chagas disease: is carbonic anhydrase a target for antiprotozoal drugs?

A Beatriz Vermelho, GC Rodrigues… - Expert Opinion on …, 2022 - Taylor & Francis
Introduction Carbonic anhydrase (CA) arose significant interest as a potential new target for
Chagas disease since its discovery in Trypanosoma cruzi in 2013. Benznidazole and …

An overview of sulfonamide‐based conjugates: Recent advances for tuberculosis treatment

CB Scarim, FR Pavan - Drug Development Research, 2022 - Wiley Online Library
Abstract In 2019, tuberculosis (TB) caused approximately 1.4 million deaths around the
world. TB is an infectious respiratory disease mainly caused by Mycobacterium tuberculosis …

The use of Sulfonamide Derivatives in the Treatment of Trypanosomatid Parasites including Trypanosoma cruzi, Trypanosoma brucei, and Leishmania ssp

CB Scarim, RC Chelucci, JL Dos Santos… - Medicinal …, 2020 - ingentaconnect.com
More than 10 million people around the world are afflicted by Neglected Tropical Diseases,
such as Chagas Disease, Human African Trypanosomiasis, and Leishmania. These …

Recent advancement and treatment of leishmaniasis based on pharmacoinformatics approach: current and future outlook

MY Ansari, MR Dikhit, GC Sahoo, V Ali, P Das - Gene reports, 2017 - Elsevier
The concept of rational treatment, target to therapy, is an old and interesting process in drug
discovery that includes the entire step from target identification to successful treatments of …

Vaccine potential of HLA‐A2 epitopes from Leishmania Cysteine Protease Type III (CPC)

MR Dikhit, A Amit, AK Singh, A Kumar… - Parasite …, 2017 - Wiley Online Library
Although the precise host‐defence mechanisms are not completely understood, T‐cell‐
mediated immune responses are believed to play a pivotal role in controlling parasite …

Immunomodulation induced through ornithine decarboxylase DNA immunization in Balb/c mice infected with Leishmania donovani

A Kumar, MR Dikhit, A Amit, A Zaidi, RK Pandey… - Molecular …, 2018 - Elsevier
We report here a Leishmania donovani ornithine decarboxylase (Ld-ODC) gene used as a
DNA vaccine against visceral leishmaniasis in a murine Balb/c mouse model. This study …

[HTML][HTML] Noninvasive sweat-based diagnosis of visceral leishmaniasis and post kala-azar dermal leishmaniasis

RK Topno, V Shankar, MR Dikhit… - The American Journal …, 2018 - ncbi.nlm.nih.gov
The diagnosis of visceral leishmaniasis (VL) is one of the foremost barriers in the control of
this disease, as demonstration of the parasite by splenic/bone marrow aspiration is relatively …

Structural characterization of naphthalene sulfonamides and a sulfonate ester and their in vitro efficacy against Leishmania tarentolae promastigotes

EW Li, J Katinas, MA Jones, CG Hamaker - New Journal of Chemistry, 2021 - pubs.rsc.org
Leishmaniasis, a parasitic infectious disease transmitted by sandfly bites, is an extremely
complex human and veterinary disease. In humans, it takes different forms ranging from self …

Computational elucidation of novel antagonists and binding insights by structural and functional analyses of serine hydroxymethyltransferase and interaction with …

MR Dikhit, MY Ansari, V Ali, RK Topno, JP Majhee… - Gene Reports, 2018 - Elsevier
The crystallographic structure of the Leishmania donovani serine hydroxymethyltransferase
(Ld SHMT), an attractive target for the design of leishmanicidal agents, is still unknown …